Medical Physics Challenges for the Implementation of Quality Assurance Programmes in Radiation Oncology

• Published in: Clinical oncology (Royal College of Radiologists (Great Britain)) 2017-02, Vol.29 (2), p.116-119
• Main Author: Meghzifene, A
• Format: Article
• Language: English
• Subjects: Challenges; Hematology, Oncology and Palliative Medicine; Humans; IAEA; International Agencies; low- and middle-income countries; Particle Accelerators; Patient Safety; Physics; quality assurance; Quality Assurance, Health Care - methods; Radiation Oncology - standards; Radiology
• ISSN: 0936-6555; 1433-2981
• DOI: 10.1016/j.clon.2016.10.008

Abstract The importance of quality assurance in radiation therapy, as well as its positive consequences on patient treatment outcome, is well known to radiation therapy professionals. In low- and middle-income countries, the implementation of quality assurance in radiation therapy is especially challenging, due to a lack of staff training, a lack of national guidelines, a lack of quality assurance equipment and high patient daily throughput. According to the International Atomic Energy Agency (IAEA) Directory of Radiotherapy Centres, the proportion of linear accelerators compared with Co-60 machines has increased significantly in recent years in low- and middle-income countries. However, this increase in the proportion of relatively more demanding technology is not always accompanied with the necessary investment in staff training and quality assurance. The IAEA provides supports to low- and middle-income countries to develop and strengthen quality assurance programmes at institutional and national level. It also provides guidance, through its publications, on quality assurance and supports implementation of comprehensive clinical audits to identify gaps and makes recommendations for quality improvement in radiation therapy. The new AAPM TG100 report suggests a new approach to quality management in radiation therapy. If implemented, it will lead to improved cost-effectiveness of radiation therapy in all income settings. Low- and middle-income countries could greatly benefit from this new approach as it will help direct their scarce resources to areas where they can produce the optimum impact on patient care, without compromising patient safety.